Beatles

Beatles is a biotechnology company focused on the development of bio-artificial organs and advanced cardiovascular therapies. The company leverages tissue engineering and regenerative medicine to create functional heart tissue and organ-scale solutions for patients with end-stage heart failure. Their primary focus is on developing a bio-artificial heart that integrates biological components with synthetic scaffolds to restore cardiac function. Beatles aims to address the global shortage of donor organs by providing scalable, lab-grown alternatives. The company is currently in the pre-clinical stage, conducting foundational research and early-stage testing of its core technologies.